PDMR/ PCA Dealings

RNS Number : 0981O
EKF Diagnostics Holdings PLC
05 October 2021
 

EKF Diagnostics Holdings plc
("EKF" or the "Company")

 

  PDMR/ PCA Dealings 

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that the Board of EKF has been informed that on Friday 1 October, 2021, certain funds connected to Christopher Mills, Non-executive Chairman, sold a total of 1,275,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 84.0 pence per Ordinary Share.

 

Following this transaction, Christopher Mills' total direct and indirect interest in the Company is 130,875,000 Ordinary Shares, representing approximately 28.76% of the total voting rights over the Company's issued share capital.

 

The Notification of Dealing Form required in accordance with UK MAR is set out below and reflects the sale of 637,500 Ordinary Shares by each of the North Atlantic Smaller Companies Investment Trust plc ("NASCIT") and the Oryx International Growth Fund Limited ("Oryx"). 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Christopher Mills

2

 

Reason for the notification

a)

 

Position/status

 

 

Christopher Mills is Non-executive Chairman of the Company. 

Mr. Mills is a partner and Chief Investment Officer of Harwood Capital LLP.  Harwood Capital LLP is Investment Manager to NASCIT.

Mr Mills is also a director of Harwood Capital Management (Gibraltar) Limited, which is Investment Manager and Investment Adviser to Oryx.

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI

 

 

213800DXTF3EAUK1AR05

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of  £0.01 each



Identification code

GB0031509804

 

 


b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£0.84

637,500

 


 

£0.84

637,500

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

1,275,000



- Price

£0.84



e)

 

Date of the transaction

 

 

1 October 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Christopher Mills, Non-executive Chairman

 Tel: +44 (0)29 2071 0570

Mike Salter, CEO

 

Richard Evans, FD & COO

 

 

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Tel: +44 ( 0)20 7496 3000

Aubrey Powell / George Tzimas / Tom Salvesen

 

 

 

Investec Bank plc (Joint Broker)

Tel: +44 (0)20 7597 4000

Gary Clarence / Daniel Adams

 

 

 

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com 

Paul McManus / Lianne Cawthorne

Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPGCCUUPGGWA
UK 100

Latest directors dealings